These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25142102)

  • 1. Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
    Wu WY; Chan HY; Tan HK
    Acta Neuropsychiatr; 2014 Feb; 26(1):61-4. PubMed ID: 25142102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose manic switch and high-dose antimanic effect and extrapyramidal symptoms by aripiprazole in a single bipolar patient.
    Park YM
    Am J Ther; 2014; 21(6):e218-20. PubMed ID: 23676345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
    J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.
    Gupta S; Masand P
    Ann Clin Psychiatry; 2004; 16(3):155-66. PubMed ID: 15517848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
    J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole for the treatment of bipolar disorder: a review of current evidence.
    Fagiolini A; Nitti M; Forgione RN; Marra FS; Casamassima F
    Expert Opin Pharmacother; 2011 Feb; 12(3):473-88. PubMed ID: 21254952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole: new indication. Treatment and prevention of manic episodes: just another neuroleptic.
    Prescrire Int; 2009 Jun; 18(101):117. PubMed ID: 19637429
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
    Raja M
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):107-10. PubMed ID: 16487453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole in the treatment of bipolar disorder in children and adolescents.
    Durkin JP
    J Child Adolesc Psychopharmacol; 2004; 14(4):505-6. PubMed ID: 15662141
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole-related tardive dyskinesia.
    Maytal G; Ostacher M; Stern TA
    CNS Spectr; 2006 Jun; 11(6):435-9. PubMed ID: 16816781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
    Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC
    Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in intractable tardive dystonia in bipolar disorder after aripiprazole treatment: a case report.
    Takagai S; Nakasato K; Suzuki K; Kasai E; Isogai S; Morimoto S; Mori N
    J Clin Psychopharmacol; 2012 Aug; 32(4):563-4. PubMed ID: 22760347
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement in tardive dyskinesia with aripiprazole use.
    Witschy JK; Winter AS
    Can J Psychiatry; 2005 Mar; 50(3):188. PubMed ID: 15830835
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of tardive dyskinesia with aripiprazole.
    Osorio RS; Agüera-Ortiz L; Hurtado de Mendoza A; Ramos I; Palomo T
    Neurotox Res; 2010 May; 17(4):432-4. PubMed ID: 19826893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
    De Schutter P; Bouckaert F; Peuskens J
    Tijdschr Psychiatr; 2011; 53(5):299-303. PubMed ID: 21538299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports.
    Karadağ F; Tan D; Unal F
    Turk Psikiyatri Derg; 2011; 22(4):269-72. PubMed ID: 22143953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.